NVIDIA Price Target Lifted to $300 by KeyBanc: Blackwell and Rubin Are Stacking Catalysts

Photo of David Moadel
By David Moadel Published

Quick Read

  • KeyBanc raised NVIDIA’s (NVDA) price target to $300 from $275 with an Overweight rating, citing Blackwell and Rubin as stacking catalysts ahead of May earnings.

  • KeyBanc’s upgrade positions Rubin as a near-term catalyst in anticipation of NVIDIA’s May 20 earnings report rather than a distant opportunity, reinforcing the company’s dominance in AI infrastructure spending despite competitive threats from hyperscaler custom chips.

  • The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
NVIDIA Price Target Lifted to $300 by KeyBanc: Blackwell and Rubin Are Stacking Catalysts

© Shutterstock / Below the Sky

NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) just picked up another bullish data point from Wall Street. KeyBanc raised its price target on NVIDIA to $300 from $275, maintaining an Overweight rating on the shares. The firm’s thesis: Blackwell and Rubin are stacking catalysts heading into the May 20 earnings report.

For long-term holders, the price target raise reinforces a narrative that has driven NVIDIA stock to a $5.46 trillion market cap and a 19% year-to-date (YTD) gain. The bull case rests on a multi-quarter Blackwell ramp, an early Rubin contribution, and a China H200 wild card that could meaningfully extend the cycle.

This analyst upgrade arrives two days before NVIDIA reports its fiscal Q1 2027 results, where consensus calls for $78 billion in revenue and $1.77 EPS. The KeyBanc note frames the print as a setup for sustained upside rather than a one-quarter event.

Ticker Company Firm Action Old Rating New Rating Old Target New Target
NVDA NVIDIA KeyBanc Price target raised Overweight Overweight $275 $300

The Analyst’s Case

KeyBanc expects NVIDIA to deliver strong results and guidance driven by several upside catalysts. The firm sees Blackwell GPU shipments rising by 150,000 to 200,000 quarter-over-quarter, adding an estimated $5 billion to $7 billion in revenue.

On the next platform, initial Rubin revenue of $3 billion to $4 billion is included in the outlook, with improving HBM4 supply supporting Rubin GPU shipments of 1.7 million to 1.8 million units this year. The wild card is geopolitics: China H200 approvals could represent $13 billion to $14 billion in potential revenue, though KeyBanc expects management to exclude this from guidance while still outlining the possible impact.

Company Snapshot

NVIDIA, led by CEO Jensen Huang, just closed a remarkable fiscal year. FY2026 revenue reached $215.94 billion, up 65% year over year (YoY), with net income of $120.07 billion and free cash flow of $96.58 billion.

The most recent quarter showed the engine still accelerating. Q4 FY2026 revenue hit $68.13 billion, up 73% YoY, with Data Center revenue of $62.31 billion and networking revenue of $10.98 billion, up 263% YoY. Management guided Q1 FY2027 revenue to roughly $78 billion, excluding any Data Center compute revenue from China.

Why the Move Matters Now

NVDA stock trades at a trailing P/E ratio of 46x and a forward P/E ratio of 27x, which is rich but supported by durable growth. The Street consensus already sits at an analyst target price of $272.94, with 48 Buy and 10 Strong Buy ratings.

KeyBanc’s $300 target moves the firm meaningfully above consensus, framing Rubin as a second-leg catalyst rather than a distant horizon. Huang noted on the last call that “we shipped our first Vera Rubin samples to customers earlier this week, and we remain on track to commence production shipments in the second half of the year.”

What It Means for Your Portfolio

For prudent investors, the revised outlook reinforces NVIDIA’s central role in the AI infrastructure build-out, but real risks remain. China policy could swing $13 billion to $14 billion either way, custom silicon from hyperscalers remains a competitive overhang, and the valuation leaves little margin for a guidance stumble.

The thesis still favors patient owners. Position sizing matters here: a measured stake lets investors participate in the Blackwell-to-Rubin transition while leaving room to add on the volatility that earnings prints like Wednesday’s tend to produce.

Photo of David Moadel
About the Author David Moadel →

David Moadel is financial writer specializing in stocks, ETFs, options, precious metals, and Bitcoin. David has written well over 1,000 articles for leading online publications, helping investors understand markets, income strategies, and risk.

His work has appeared in The Motley Fool, InvestorPlace, U.S. News & World Report, TipRanks, ValueWalk, Benzinga, Market Realist, TalkMarkets, Finmasters, 24/7 Wall St., and others.

With a master’s degree in education, David has taught at the elementary, high school, and college levels. That teaching background shapes his writing style: clear, educational, and practical. David has also built a loyal social-media audience by providing trustworthy financial content on YouTube, X/Twitter, and StockTwits.

Continue Reading

Top Gaining Stocks

D Vol: 16,174,931
FDS Vol: 217,342
CTSH Vol: 4,153,564
FICO Vol: 141,938
NOW Vol: 23,334,828

Top Losing Stocks

REGN Vol: 1,526,345
CTRA Vol: 73,319,495
STX Vol: 1,787,338
GLW Vol: 6,275,085
WDC Vol: 2,559,390